![Is there any reason for going higher than 50mg? The SERT occupancy is almost maximum at this dose and higher doses give minimum aditional benefit. Some studies suggest that is not increasing Is there any reason for going higher than 50mg? The SERT occupancy is almost maximum at this dose and higher doses give minimum aditional benefit. Some studies suggest that is not increasing](https://preview.redd.it/zylhppxrieg81.jpg?auto=webp&s=20d787f9592cc8374dc90445a8cdef4dfcfd82cc)
Is there any reason for going higher than 50mg? The SERT occupancy is almost maximum at this dose and higher doses give minimum aditional benefit. Some studies suggest that is not increasing
filosoffen.dk - what is metformin 500 mg used for | Right! think, increasing sertraline dose side effects the expert
![Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis - The Lancet Psychiatry Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/36844a58-67d6-4241-9a0e-b134c8078cc5/gr2_lrg.jpg)
Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis - The Lancet Psychiatry
![The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial - The Lancet Psychiatry The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/79c3fdd6-6029-43cf-bf78-a9fa56502475/gr1_lrg.gif)
The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial - The Lancet Psychiatry
![Frontiers | The Antidepressant Sertraline Reduces Synaptic Transmission Efficacy and Synaptogenesis Between Identified Lymnaea Neurons Frontiers | The Antidepressant Sertraline Reduces Synaptic Transmission Efficacy and Synaptogenesis Between Identified Lymnaea Neurons](https://www.frontiersin.org/files/Articles/603789/fmars-07-603789-HTML-r1/image_m/fmars-07-603789-g001.jpg)